TITLE

Clinical evaluation of Rasayana compound as an adjuvant in the management of tuberculosis with anti-Koch's treatment

AUTHOR(S)
Vyas, Purvi; Chandola, H. M.; Ghanchi, Firoz; Ranthem, Shivprakash
PUB. DATE
January 2012
SOURCE
AYU: An International Quarterly Journal of Research in Ayurveda;Jan-Mar2012, Vol. 33 Issue 1, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Tuberculosis (TB) continues to intimidate the human race since time immemorial not only due to its effects as a medical malady, but also by its impact as a social and economic tragedy. At the dawn of the new millennium, we are still mute witnesses to the silent yet efficient march of this sagacious disease, its myriad manifestations and above all its unequalled, vicious power. Through the millennia, TB never ever disappeared from the developing world. In 1991, the World Health Assembly (WHA) resolution recognized TB as a major global public health problem. The DOTS strategy was launched in 1994, and became the global recommended strategy for TB control since then. The present study deals with clinical evaluation of Rasayana drugs considering of Amalaki (Emblica officinalis Gaertn.), Guduchi (Tinospora cordifolia willd.), Ashwagandha (Withania somnifera L.) Dunal, Yastimadhu (Glycyrrhiza glabra Linn.), Pippali (Piper longum Linn.), Sariva (Hemidesmus indicus R.Br.), Kustha (Saussurea lappa Falc.), Haridra (Curcuma longa Linn.) and Kulinjan (Alpinia galangal Linn.) as an adjuvant therapy with anti-Koch's treatment. The results obtained revealed that Rasayana compound was found to decrease cough (83%), fever (93%), dyspnea (71.3%), hemoptysis (87%) and increase body weight (7.7%) with statistically highly significant (P<0.001).
ACCESSION #
80214902

 

Related Articles

  • Latent tuberculosis infection: old problem, new priorities. Schwartzman, Kevin // CMAJ: Canadian Medical Association Journal;3/19/2002, Vol. 166 Issue 6, p759 

    Comments on control programs for latent tuberculosis (TB) in North America. Public health practice of providing tuberculin testing to those with newly diagnosed HIV infection and others at risk; Use of tuberculin skin testing with purified protein derivative for detecting latent TB; Use of...

  • Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: A case control study.  // BMC Public Health;2011, Vol. 11 Issue 1, p696 

    The article offers information on a study conducted by the authors on factors related to treatment default in tuberculosis patients in Nairobi, Kenya. The study included 945 defaulters and others who completed the treatment between 2006-2008. It states that they attributed default to ignorance,...

  • Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.  // MMWR: Morbidity & Mortality Weekly Report;6/9/2000 Supplement RR-6, Vol. 49 Issue 22, p1 

    Recommends targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI). Principle involved in targeted tuberculin testing; History of the treatment of LTBI; Relationship of tuberculin testing to treatment of LTBI; Risk factors for infection with...

  • Programmatic Impact of QuantiFERON-TB Gold In-Tube Implementation on Latent Tuberculosis Diagnosis and Treatment in a Public Health Clinic. Shah, Maunank; DiPietro, Danielle; Greenbaum, Adena; Ketemepi, Sherry; Martins-Evora, Maria; Marsiglia, Vincent; Dorman, Susan E. // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: QuantiFERON-TB Gold In-Tube (QFT-GIT) is considered an alternative to the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB) infection, but the programmatic impact of QFT-GIT implementation is largely unknown. In March, 2010, the Baltimore City Health Department (BCHD)...

  • Field ion microscopy and imaging atom-probe mass spectroscopy of superconducting YBa2Cu3O7-x. Kellogg, G. L.; Brenner, S. S. // Applied Physics Letters;11/30/1987, Vol. 51 Issue 22, p1851 

    The structure and composition of the superconducting oxide YBa2Cu3O7-x have been examined in atomic detail by field ion microscopy and imaging atom-probe mass spectroscopy. The field ion samples were prepared from hot-pressed disks of the oxide powders. Atomic resolution images were obtained...

  • Stevens' cure: a secret remedy. Newsom, S. W. B. // Journal of the Royal Society of Medicine;Sep2002, Vol. 95 Issue 9, p463 

    The article comments on issues concerning a cure, a herbal medicine which guarantees treatment of a patient with consumption using a formula containing 80 grains of umckaloabo root with 13½ grains of chichitse per ounce prepared according to British Pharmacopeia methods. Information regarding...

  • THE EFFECT OF COMBINING HERBAL AND SYNTHETIC MEDICINES ON STABILITY ANALYSIS OF TUBERCULOSIS SPREADING DISEASE MODEL (CASE STUDY: TUBERCULOSIS IN BOGOR REGION, WEST JAVA, INDONESIA). Rohaeti, Embay; Wardatun, Sri; Andriyati, Ani // Far East Journal of Mathematical Sciences;Nov2015, Vol. 98 Issue 6, p769 

    Synthetic drugs that commonly used for healing tuberculosis disease are: isoniazid, rifampicin, ethambutol and pyrazinamide. Healing tuberculosis disease takes a very long time usually from 6 until 9 months. Besides that, patients also need to pay a lot of money for the treatments. Moreover,...

  • THE DAILY ROUTINE OF PATIENTS IN TUBERCULOSIS TREATMENT IN BASIC HEALTH CARE UNITS: A PHENOMENOLOGICAL APPROACH. Paz, Elisabete Pimenta Araújo; Sá, Antonia Margareth Moita // Revista Latino-Americana de Enfermagem (RLAE);mar/abr2009, Vol. 17 Issue 2, p180 

    This study presents a phenomenological reflection on the daily care routine of patients in TB treatment. It aimed to understand the routine of treatment delivered at the primary health care service. Phenomenological interviews were carried out with patients infected with TB and health...

  • Affiliate helps improve tuberculosis laws in Ohio.  // Nation's Health;Mar2001, Vol. 31 Issue 2, p10 

    Reports that the Ohio Public Health Association members helped craft a tuberculosis law in Ohio and lobbied for its passage. Information on the tuberculosis control program under the law; Procedures for the detention of people who refuse tuberculosis treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics